Assessing innovative care models for musculoskeletal disorders’ management in the emergency department using Time-Driven Activity-Based Costing - Gagnon, Rose; Perreault, Kadija; Guertin, Jason R.; Hébert, Luc J.; Berthelot, Simon (medRxiv, 2024)
Objectives Compare the average cost of an emergency department (ED) visit between three ED care models, namely management by an emergency physician (EP) alone (usual care), management by a primary contact physiotherapist (PT) and an EP (intervention), and management by a PT alone (sensitivity analysis).Methods Cost study (Canadian Public Payer perspective) based on data collected during a pragmatic randomized clinical trial (2018-2019) conducted in an urban Canadian academic ED (CHUL, Quebec City, Canada; n=78, 18-80 years old). Costs incurred for the management of persons presenting to the ED for a minor musculoskeletal disorder (MSKD) were calculated using Time-Driven Activity-Based Costing, in which time invested with a patient determines care costs. The main outcome measure was the average cost of an ED visit. Generalized linear models with Gamma distributions and log links were used to assess whether there were significant differences in average costs between the care models.Results Mean ED visit cost was $278.47 (2019 $CAD, 95%CI: $223.70, $357.42) for PT and EP management, compared with $254.68 for EP management ($178.48, $346.68), resulting in a non-significant absolute difference of 23.79 CAD/patient ($-87.04, $135.74) between models (p=.58). Sensitivity analyses showed that the average cost of ED management by a PT was $194.40 ($160.86, $235.14), representing a non-significant average saving of 60.28 CAD/patient ($-168.19, $31.46) compared to EP management.Conclusion This study is a first step towards a better understanding of the costs incurred by the Canadian Public Payer for the management of persons presenting with MSKDs in the ED. Primary contact physiotherapists have the potential to complement care of MSKD ED patients without increasing healthcare costs.Competing Interest StatementThe authors have declared no competing interest.Clinical TrialNCT04009369Clinical Protocols https://doi.org/10.1371/journal.pone.0277369 Funding StatementPart of the data that were used in this study were acquired during a randomized clinical trial supported by the CHU de Quebec Universite Laval, subsidies from LJH and KP, and a clinical research scholarship awarded to one of the CHU de Quebec collaborators by the Fondation du CHU de Quebec for the multidisciplinary council of the CHU de Quebec Universite Laval. RG received scholarships from the Canadian Institutes of Health Research (CIHR), the Fonds de recherche Quebec Sante (FRQ-S), the Unite de soutien SSA Quebec, the Ordre professionnel de la physiotherapie du Quebec, the Centre interdisciplinaire de recherche en readaptation et integration sociale (Cirris) and Universite Laval. SB and JRG are FRQ-S Research Scholars. The funding organizations had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Ethics committee/IRB of CHU de Quebec – Universite Laval gave ethical approval for this work (#MP-20-2019-4307)I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.YesAll data produced in the present study are available upon reasonable request to the authors.